<DOC>
	<DOCNO>NCT02917512</DOCNO>
	<brief_summary>A multicenter , Placebo control , RestasisÂ® reference , Randomized , Double blind , Phase II Study Evaluate Efficacy Safety HU00701/HU007 Eye Drops Adult Patients Dry Eye Syndrome</brief_summary>
	<brief_title>Efficacy Safety Study HU00701/HU007 Eye Drops Patients With Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>age 19 Corneal stain score ( Oxford grade ) &gt; 2 Schirmer test &lt; 10mm/5min ( If Schirmer test = 0mm/5min , Nasal stimulation schirmer test &gt; 3mm/5min ) Volunteer go menopause 1 year ago screen surgical menopause Volunteer negative result pregnancy test use effective contraception Current recent patient use dry eye syndrome medication ( topical systemic ) may affect status The patient systemic ocular disorder affect test result Being treat systemic steroid Wearing contact lenses within 3 day screen visit Pregnancy Breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>